New FCC rules on broadband companies being put on hold, a hearing on the FTC’s bid to block the Kroger-Albertsons deal, a potential key ruling in Zantac litigation against GSK and others are catalysts to watch for in August. In this Bloomberg Intelligence litigation and policy outlook episode of the Votes and Verdicts podcast host, BI senior litigation analyst Elliot Stein, gathered colleagues to discuss these and other matters. These include Part D drug-pricing announcements, a Bristol Myers bid to dismiss a suit related to its acquisition of Celgene, a hearing regarding the location of a lawsuit challenging the CFPB’s credit-card late-fee cap and an anticipated ruling to block the FTC’s outlawing noncompete agreements. We also discussed the election’s impact on crypto and healthcare. See omnystudio.com/listener for privacy information.